Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-05 4:36 pm Unchanged |
2025-03-05 | 13D | COMPASS Pathways plc CMPS |
ATAI Life Sciences N.V. ATAI |
6,905,774 7.500% |
0 (Unchanged) |
Filing History |
| 2025-02-24 9:59 pm Purchase |
2025-02-14 | 13D | IntelGenx Technologies Corp. IGXT |
Apeiron Investment Group Ltd. | 44,908,967 22.700% |
44,908,967 (New Position) |
Filing History |
| 2024-09-27 7:56 pm Sale |
2024-09-26 | 13D | COMPASS Pathways plc CMPS |
ATAI Life Sciences N.V. ATAI |
6,905,774 10.100% |
-2,529,984 (-26.81%) |
Filing History |
| 2024-05-03 4:06 pm Purchase |
2024-04-19 | 13D | IntelGenx Technologies Corp. IGXT |
ATAI Life Sciences N.V. ATAI |
263,032,812 65.700% |
5,405,405 (+2.10%) |
Filing History |
| 2024-03-12 9:30 pm Sale |
2023-09-30 | 13D | IntelGenx Technologies Corp. IGXT |
ATAI Life Sciences N.V. ATAI |
257,627,407 65.200% |
-51,693 (-0.02%) |
Filing History |
| 2024-02-13 4:29 pm Purchase |
2023-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 33,885,999 20.100% |
1,214,297 (+3.72%) |
Filing History |
| 2023-09-06 9:22 pm Purchase |
2023-08-31 | 13D | IntelGenx Technologies Corp. IGXT |
ATAI Life Sciences N.V. ATAI |
257,679,100 65.200% |
23,999,100 (+10.27%) |
Filing History |
| 2023-02-10 08:39 am Purchase |
2022-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 32,671,702 19.400% |
612,198 (+1.91%) |
Filing History |
| 2022-03-01 4:30 pm Purchase |
2021-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Galaxy Group Funding ECI U LLC | 10,796,736 6.700% |
10,796,736 (New Position) |
Filing History |
| 2022-02-10 5:01 pm Purchase |
2021-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 32,059,504 19.700% |
32,059,504 (New Position) |
Filing History |
| 2021-12-01 1:31 pm Purchase |
2021-11-29 | 13D | COMPASS Pathways plc CMPS |
ATAI Life Sciences N.V. ATAI |
9,435,758 22.600% |
741,000 (+8.52%) |
Filing History |
| 2021-11-29 07:23 am Purchase |
2021-11-24 | 13D | COMPASS Pathways plc CMPS |
ATAI Life Sciences N.V. ATAI |
8,694,758 20.800% |
619,095 (+7.67%) |
Filing History |
| 2021-05-24 4:54 pm Purchase |
2020-12-29 | 13D | COMPASS Pathways plc CMPS |
ATAI Life Sciences N.V. ATAI |
8,075,663 19.700% |
8,075,663 (New Position) |
Filing History |
| 2021-05-24 4:30 pm Purchase |
2021-05-14 | 13D | IntelGenx Technologies Corp. IGXT |
ATAI Life Sciences N.V. ATAI |
233,680,000 67.600% |
233,680,000 (New Position) |
Filing History |